Abstract
NRG1, encoding neuregulin 1, is a susceptibility gene for schizophrenia, but no functional mutation causally related to the disorder has yet been identified. Here we investigate the effects of a variant in the human NRG1 promoter region in subjects at high risk of schizophrenia. We show that this variant is associated with (i) decreased activation of frontal and temporal lobe regions, (ii) increased development of psychotic symptoms and (iii) decreased premorbid IQ.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
David, A.S. et al. Psychol. Med. 27, 1311–1323 (1997).
Lawrie, S.M., Johnstone, E.C. & Weinberger, D.R. Schizophrenia: From Imaging to Neuroscience (Oxford Univ. Press, New York, 2004).
Corfas, G., Roy, K. & Buxbaum, J.D. Nat. Neurosci. 7, 575 (2004).
Badner, J.A. & Gershon, E.S. Mol. Psychiatry 7, 405–411 (2002).
Stefansson, H. et al. Am. J. Hum. Genet. 71, 877–892 (2002).
Stefansson, H. et al. Am. J. Hum. Genet. 72, 83–87 (2003).
Li, D., Collier, D.A. & He, L. Hum. Mol. Genet. 15, 1995–2002 (2006).
Law, A.J. et al. Proc. Natl. Acad. Sci. USA 103, 6747–6752 (2006).
Johnstone, E.C. et al. Schizophr. Res. 46, 1 (2000).
Whalley, H.C. et al. Brain 127, 478–490 (2004).
Williams, L.M. et al. Am. J. Psychiatry 161, 480–489 (2004).
Marjoram, D. et al. Neuroimage 31, 1850–1858 (2006).
Honey, G.D. et al. Psychol. Med. 33, 1007–1018 (2003).
Friston, K.J. & Frith, C.D. Clin. Neurosci. 3, 89–97 (1995).
Green, E.K. et al. Arch. Gen. Psychiatry 62, 642–648 (2005).
Acknowledgements
We thank P. Miller for assistance with data management. This work was funded by the Dr Mortimer and Theresa Sackler Institute Foundation, the UK Medical Research Council (Programme Grants G9226254 and G9825423 awarded to E.C.J. and colleagues, and G0100266 awarded to D.J.P. and colleagues) and the Stanley Medical Research Institute (for support of B.J.B). Imaging was conducted at the Scottish Higher Education Funding Council Brain Imaging Research Centre, Edinburgh. Genotyping was performed at the Wellcome Trust Clinical Research Facility Genetics Core.
Author information
Authors and Affiliations
Contributions
J.H. investigated the association of NRG1 with psychotic symptoms in this cohort and wrote the manuscript. H.C.W. and J.H. conducted the fMRI analysis. D.E.J. conducted the structural MRI analysis. B.J.B. collected the blood samples and A.M.M. gave advice regarding data analysis. K.L.E. and P.A.T. contributed to the analysis of the genetic data and D.J.P. supervised the genetic component of the project. E.C.J. designed and implemented the project. D.G.C.-O. and E.C.J. conducted the clinical assessments. S.M.L. supervised the neuroimaging.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Graphs represent parameter estimates and 90% confidence intervals for the 3 genotype groups in the contrast of sentence completion versus rest at peak voxels in medial prefrontal cortext and right temporo-occipital junction. (PDF 34 kb)
Supplementary Table 1
Additional marker information. (PDF 82 kb)
Supplementary Table 2
Symptom severity. (PDF 59 kb)
Supplementary Table 3
Symptom type. (PDF 45 kb)
Supplementary Table 4
fMRI data excluding related subjects. (PDF 56 kb)
Rights and permissions
About this article
Cite this article
Hall, J., Whalley, H., Job, D. et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 9, 1477–1478 (2006). https://doi.org/10.1038/nn1795
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn1795
This article is cited by
-
NRG1 knockdown rescues PV interneuron GABAergic maturation deficits and schizophrenia behaviors in fetal growth restriction mice
Cell Death Discovery (2022)
-
Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients
Translational Psychiatry (2022)
-
An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data
Molecular Psychiatry (2022)
-
Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice
Scientific Reports (2018)
-
Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders
Molecular Psychiatry (2018)